Acclaro Medical Highlights UltraClear and AuraLux Lasers in Marketing Push

According to a recent LinkedIn post from Acclaro Medical, the company is spotlighting its UltraClear and AuraLux laser platforms through a themed April Fools campaign. The post frames the UltraClear Laser as the lead in a fictional series called “Love is CLEAR,” while AuraLux is positioned as the star of “Too RADIANT Too Handle.”

Although presented humorously, the campaign suggests an effort to build brand awareness around Acclaro Medical’s 2910 nm fiber laser technology. For investors, this could indicate continued investment in marketing to differentiate its aesthetic laser portfolio and potentially drive practitioner and patient interest.

The emphasis on two distinct laser brands implies a multi-product strategy targeting the skin resurfacing and skin rejuvenation segments. If these technologies gain traction with clinics and med-spa operators, Acclaro Medical could benefit from recurring device and consumable revenue streams.

The post does not disclose pricing, regulatory, or commercial performance details, so concrete financial impact cannot be inferred. However, the focus on product personalities and consumer-style engagement may reflect a competitive positioning approach in the aesthetic device market, where patient demand and brand recall can influence capital equipment purchasing decisions.